Er Boston Scientific utbyttet sikkert?
Boston Scientific har økt utbyttet i 0 år.
I løpet av de siste 10 årene har Boston Scientific økt denne med årlig 0 % senket.
På 5-års sikt falt utbyttet med 0 %.
Analytikerne forventer en Utbetalingssenkning på −100,000% for det pågående regnskapsåret.
Boston Scientific Aktienanalyse
Hva gjør Boston Scientific?
Boston Scientific Corp. is a global medical technology company specializing in the development and manufacturing of innovative solutions for medical challenges and needs. The company was founded in 1979 and has since been dedicated to meeting the individual needs of patients and medical professionals with innovative products.
The history of Boston Scientific began in the 1960s when French engineer Jean-Marc Simon started developing pacemakers at the University of Minnesota. In 1969, Medtronic acquired Simon's pacemaker development, leading to the founding of Boston Scientific. From the beginning, the company focused on the production of cardiovascular implants, including pacemakers, implanted defibrillators, and stents.
In the following years, the company achieved continued growth through acquisitions of competitors and advancements in research and development, particularly in the field of minimally invasive procedures. Today, Boston Scientific is a globally leading provider of innovative medical devices and solutions used in various areas of healthcare.
Boston Scientific's business model is based on meeting the needs of patients, medical professionals, and healthcare policymakers in order to improve healthcare. The company works closely with doctors, hospitals, nursing facilities, and research institutions to continuously develop innovative solutions for various diseases and conditions.
Boston Scientific has five business segments: Cardiovascular Systems, Interventional Oncology and Neuromodulation, Urology and Women's Health, Medical Oncology, and Endoscopy.
The Cardiovascular Systems segment includes products and solutions for cardiovascular surgery, including pacemakers, implanted defibrillators, and catheters. The company is also involved in endovascular surgery, offering innovative stent and catheter systems for the treatment of aneurysms and arterial occlusive disease.
The Interventional Oncology and Neuromodulation segment includes solutions for the minimally invasive treatment of cancer and chronic pain through catheter and implant systems. For example, Boston Scientific offers intensity-controlled radiofrequency ablation and neuromodulation procedures.
The Urology and Women's Health segment includes products for the treatment and diagnosis of urogenital system disorders, including incontinence, urinary incontinence, and genital diseases. Boston Scientific offers innovative solutions for women, such as the treatment of urinary incontinence or the removal of uterine fibroids.
The Medical Oncology segment includes products for the diagnosis and treatment of cancer, including in vitro diagnostics and novel treatments such as chemotherapy delivery technology.
The Endoscopy segment includes endoscopic solutions, including the diagnosis and therapy of digestive tract, chest, and lung disorders.
Boston Scientific's product portfolio is diverse and includes numerous innovative medical devices and systems designed to meet the needs of patients and medical professionals. Some of the notable products of the company include:
- The Implantable Cardioverter-Defibrillator (ICD) is an innovative device that can treat heart rhythm disorders through the use of a remote control.
- Drug-Eluting Stents are stents that deliver medication directly at the site of narrowing, promoting blood flow and helping to keep the artery open.
- The Synergy is a top-of-the-line stent that has both a lower mortality rate and a higher success rate than conventional stents.
- The Venus-EP Steerable Sheath is an advanced catheter that allows physicians unique navigation within the heart chambers.
- The Precision is a catheter that sends impulses to the heart for the diagnosis and treatment of atrial fibrillation.
- The Transcend is a pacemaker that combines traditional pacemaker function with a sensor that actively supports the patient during physical activity.
- The Symphion is an innovative system for laparoscopic surgery that enables minimally invasive surgical procedures in women.
In conclusion, Boston Scientific Corp. is a globally leading provider of innovative medical devices and solutions that run like a common thread through its various business segments. With a significant focus on research and development, the company offers a wide range of products to ensure that patients worldwide have access to innovative medical care. Through pioneering innovations, the development of new technologies, and collaboration with medical professionals, Boston Scientific will continue to defend its position as a leading provider of medical solutions worldwide. Boston Scientific er et av de mest populære selskapene på Eulerpool.com.Aksjespareplaner tilbyr en attraktiv mulighet for investorer å bygge opp formue over tid. En av de største fordelene er den såkalte kostnadsgjennomsnittseffekten: Ved regelmessig å investere et fast beløp i aksjer eller aksjefond, kjøper man automatisk flere andeler når prisene er lave, og færre når de er høye. Dette kan føre til en lavere gjennomsnittspris per andel over tid. I tillegg gir aksjespareplaner også småsparere tilgang til dyre aksjer, siden de kan delta med små beløp. Den regelmessige investeringen fremmer også en disiplinert investeringsstrategi og hjelper med å unngå emosjonelle beslutninger, som impulsiv kjøping eller salg. Videre drar investorer nytte av potensiell verdistigning på aksjene, samt utbytteutdelinger som kan reinvesteres, noe som forsterker rentes renteeffekten og dermed veksten av det investerte kapitalet.
Boston Scientific-aksjen kan inngå i spareplaner hos følgende tilbydere: Trade Republic